会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • CRYSTAL FORMS OF ASTAXANTHIN
    • 阿司匹林的晶体形式
    • US20140221694A1
    • 2014-08-07
    • US14245930
    • 2014-04-04
    • DSM IP ASSETS B.V.
    • Jingfei GUOMatthew J. JONESChristian SCHAEFERJoachim ULRICHViviane VERLHAC-TRICHET
    • A23K1/16A23K1/18
    • C07C403/24A23K20/179A23K50/80A23L5/44A61K9/0056C07B2200/13Y02A40/818
    • The invention describes previously undisclosed crystal forms of astaxanthin designated crystal form I and II. It has been surprisingly found that the two crystal forms of astaxanthin show an improved bioavailability, a relatively high solubility in specific organic solvents and an increased long-term stability. For example the new forms are stable in solid form for at least 90 days at a temperature of 20° C.-40° C. It was further found that the two crystal forms can be prepared from each other. Therefore the invention also relates to methods for preparing said crystal forms. In addition, the invention relates to administration forms (hereinafter also called “formulations”) comprising one of the two crystal forms according to the invention or mixtures thereof dissolved or suspended in oil or organic-solvent.
    • 本发明描述了以前未公开的虾青素晶体形式,其指定为I型和II型晶体。 已经令人惊讶地发现,两种虾青素的晶体形式具有改善的生物利用度,在特定的有机溶剂中的相对较高的溶解度和增加的长期稳定性。 例如,新的形式在20℃-40℃的温度下以固体形式稳定至少90天。进一步发现,两种晶型可以彼此制备。 因此,本发明还涉及制备所述晶形的方法。 此外,本发明涉及包含根据本发明的两种晶型之一或其溶解或悬浮在油或有机溶剂中的混合物的给药形式(以下也称为“制剂”)。